Vogt–Koyanagi–Harada disease Vogt–Koyanagi–Harada disease Vogt–Koyanagi–Harada disease (VKH), also known as Vogt–Koyanagi–Harada syndrome, uveomeningitis syndrome and uveomeningoencephalitic syndrome, is a multisystem disease of presumed autoimmune cause, that affects pigmented tissues, which have melanin. The most significant manifestation is bilateral, diffuse uveitis, which affects the eye. VKH may variably also involve the inner ear with effects on hearing, the skin, and the meninges of the central nervous system. The disease is characterised by bilateral diffuse uveitis, with pain, redness and blurring of vision. The eye symptoms may be accompanied by a varying constellation of systemic symptoms, such as auditory (tinnitus, vertigo, and hypoacusis), neurological
American Tinnitus Association to proficiently treat and diagnose tinnitus patients. Jack Vernon, Ph.D. joined Dr. Charles Unice to form the ATA in 1971. The two met while Dr. Vernon was conducting clinical research at the Oregon Health Sciences University in Portland, OR and began treating Dr. Unice for his tinnitus condition. With aim to raise money for tinnitus funding, the ATA was born. Portland, OR still serves as base for the organization. The ATA started in a small studio sized office and was staffed by Portland area volunteers. Since then the ATA has become the largest group of individual contributors that awards grant